MODULE 1 (theory)

MODULE 1 (theory)

Immunotherapy in 1st line among ALK positive patients

Prof. Joachim Aerts

Treatment of 1st line ALK+ patients: testing and sequencing

Dr. Laura Mezquita

Inloggen